Image of two soldiers looking at a drone
Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Artificial intelligence-based defense technology designer Droneshield Ltd (ASX:DRO) has seen its share price spike up more than 4% on news of a $13.5 million contract from a US government customer for its dismounted Counter-UxS (or C-UxS) systems.

The contract was for a repeat order of the C-UxS systems – which target multi-domain aerial, ground and maritime surface drones – with the product delivery and cash receipt both factored into for completion by the end of 2024.

Droneshield director of Business Development Tom Branstetter said the contract was evidence of client confidence in the company’s suite of drone defense products.

“DroneShield’s ability to rapidly deliver high-performance, lifesaving technology at this scale sets us apart in the counter-UAS industry, empowering our clients with cutting-edge solutions precisely when they need it,” he said.

At 10:49 AEDT, shares in Droneshield were trading at $1.40 – a rise of 4.89% since the market opened.

Join the discussion: See what HotCopper users are saying about Droneshield and be part of the conversations that move the markets.

dro by the numbers
More From The Market Online

Altitude Minerals kicks off drilling at Byrock copper-gold project

Altitude Minerals is testing a number of compelling RC drill targets recently confirmed at the Byrock…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham: Has crypto lost its magic? Investors rethink ‘digital gold’ narrative

Bitcoin and the crypto market built its reputation on a simple promise: buy and hold it, and eventually you’ll be rewarded, but right

Australian Oil Company ramping up Surat Basin development

Australian Oil Company is ramping up oil and gas production growth at its Surat Basin operations…

Echo IQ teams up with Mayo Clinic to evaluate AI cardiac risk tool in cancer patients

Echo IQ has secured a research collaboration with Mayo Clinic to evaluate its AI-powered cardiac risk…